Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05268250 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families

Study acronym: R2D2
StatusRecruiting
PhaseNot applicable
Started2024-02-26
View on ClinicalTrials.gov ↗
This R01 is in response to RFA-DK-19-021, Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes. The objective is to test the feasibility and acceptability of a novel, practical, and potentially scalable screen to treat program for diabetes distress in families of school-age children with T1D (called Remedy to Diabetes Distress \[R2D2\]) and to test the initial efficacy of R2D2 to reduce diabetes distress to improve children's glycemic control.

Amendment history 3 changes detected by DataLookout

2026-09-02
Enrollment reopened
2026-09-02
Primary completion pushed: 2026-08-31 → 2027-08-31
2026-09-02
Completion pushed: 2026-08-31 → 2027-08-31
Trial Details
NCT Number NCT05268250
Lead Sponsor Nemours Children's Clinic
Collaborators: Children's Mercy Hospital Kansas City
Conditions Type 1 Diabetes
Enrollment 180 participants
Start Date 2024-02-26
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-01